Sign Up to like & get
recommendations!
1
Published in 2019 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2019.00972
Abstract: Calcium-activated K+ channels constitute attractive targets for the treatment of neurological and cardiovascular diseases. To explain why certain 2-aminobenzothiazole/oxazole-type KCa activators (SKAs) are KCa3.1 selective we previously generated homology models of the C-terminal calmodulin-binding domain…
read more here.
Keywords:
cam;
kca channel;
channel activators;
structure ... See more keywords